0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Clinical Challenge | 
Hsien-Yi Chiu, MD; Nai-Lun Yeh, MD
JAMA. 2014;312(21):2281-2282. doi:10.1001/jama.2014.13029.

The Art of JAMA | 
Carrie A. Butt
JAMA. 2014;312(17):1722-1723. doi:10.1001/jama.2013.279811.

The Art of JAMA | 
Jeanette M. Smith, MD
JAMA. 2014;312(12):1180-1181. doi:10.1001/jama.2013.279741.

Original Investigation | 
Wen-Hung Chung, MD, PhD; Wan-Chun Chang, MS; Yun-Shien Lee, PhD; et al.
JAMA. 2014;312(5):525-534. doi:10.1001/jama.2014.7859.
Includes: Supplemental Content

JAMA Clinical Challenge | 
Hsien-Yi Chiu, MD; Hsien-Ching Chiu, MD
JAMA. 2013;310(10):1068-1069. doi:10.1001/jama.2013.276214.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2013;309(4):333. doi:10.1001/jama.2013.22.

JAMA Clinical Challenge | 
Jeffery B. Shackelton, MD; Joseph C. English, MD
JAMA. 2011;306(20):2267-2268. doi:10.1001/jama.2011.1728.

Health Agencies Update | 
Tracy Hampton, PhD
JAMA. 2004;291(8):933. doi:10.1001/jama.291.8.933-d.

From the Food and Drug Administration | 
Stuart L. Nightingale, MD
JAMA. 1998;280(10):872. doi:10.1001/jama.280.10.872.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Dermatology
Case Report/Case Series  | 
MEK Inhibitor–Induced Dusky Erythema:  Characteristic Drug Hypersensitivity Manifestation in 3 Patients
Urvi Patel, MD; Lynn Cornelius, MD; Milan J. Anadkat, MD
JAMA Dermatology
Case Report/Case Series  | 
Acute Generalized Exanthematous Pustulosis Caused by Dihydrocodeine Phosphate in a Patient With Psoriasis Vulgaris and a Heterozygous IL36RN Mutation
Noriaki Nakai, MD, PhD; Kazumitsu Sugiura, MD, PhD; Masashi Akiyama, MD, PhD; et al.
JAMA Dermatology
Case Report/Case Series  | 
Involution of Eruptive Melanocytic Nevi on Combination BRAF and MEK Inhibitor Therapy
Frank W. Chen, MD; Diane Tseng, MD, PhD; Sunil Reddy, MD; et al.
JAMA Dermatology
JAMA Dermatology Clinicopathological Challenge  | 
A Striking, Localized Eruption
Amanda J. Tschetter, MD; Mary S. Stone, MD; Marta J. VanBeek, MD